Results from a Phase I Clinical Trial of HBED
The experience of the past dozen years clearly indicates that iron plays a significant role in the pathogenesis of a wide variety of disease states apart from hemochromatosis. 1 In cases of rheumatoid arthritis and reperfusion injury, iron catalyzes the formation of free radicals which destroy membranes and thereby lead to tissue damage. Sequestration of this iron would obviate much of this damage. In lymphopro-liferative disorders and parasitic diseases such as malaria, iron serves as an essential nutrient for dividing cells. Withholding iron would inhibit cell division and hence slow the progression of such diseases. While unlikely to affect cures, chelation of iron would undoubtedly be of benefit as adjunctive therapy in these and related disorders.
KeywordsCholesterol Zinc Toxicity Magnesium Creatinine
Unable to display preview. Download preview PDF.
- 11.M.B. Agarwal, S.S. Gupte, D. Vasandani, C. Viswanathan, R.R. Puniyani, J. Rananathan, D.E. Massil, S. Shah, G.C. Rajyadhyaksha, and A.A. Bhave, Efficacy and safety of 1,2-dimethyl-3-hydroxypyrid-4-one (L1) as an oral iron chelator in patients of ß-thalassemia major with iron overload, J. Assoc. Phys. (India) J. A. P. I. 39: 669 (1991).Google Scholar
- 16.R.W. Grady, and A. Jacobs, The screening of potential iron chelating drugs, in: “Development of Iron Chelators for Clinical Use: Proceedings of the Second Symposium on the Development of Iron Chelators for Clinical Use,” A.E. Martell, W.F. Anderson and D.G. Badman, eds., Elsevier North Holland, Inc., New York (1981).Google Scholar
- 17.R.W. Grady, A.D. Salbe, M.W. Hilgartner and P.J. Giardina, Preliminary results from a phase I clinical trial of HBED, in: “The Development of Iron Chelators for Clinical Use,” R.J. Bergeron and G.M. Brittenham, eds., CRC Press, Inc., Boca Raton (1993).Google Scholar
- 20.J.A. Harris, and F.G. Benedict, A biometric study of basal metabolism in man, in: “Publication No. 279,” Carnegie Institution, Washington, D. C. (1919).Google Scholar